main content start
How do you like the content?
Myelodysplastic Syndromes 3m 18s

Anemia of MDS

Published 04 Oct 2022
Anemia is common feature of MDS with 90% patients having anemia at diagnosis or initial presentation. Anemia not only impacts quality of life but is also prognostic in nature.
Transfusion dependent MDS patients have worse prognosis compared to transfusion independent patients. Iron overload associated with transfusion dependence contributes to worse prognosis. Low risk patients are often treated with Erythropoietin, Luspatercept can considered for patients with ring sideroblasts while high risk patients are treated with Hypomethylating agents. Lenalidomide is particularly useful for patients with Del 5-q abnormality.
anemia mds transfusion dependence

Disclaimer: The Views/Opinions expressed and/or opinions provided in Videos and other content on MedEnrich Website are those of respective speakers. They do not purport to reflect the opinion or views of Dr.Reddy’s Laboratories Limited or its affiliates (collectively Dr.Reddy’s)in any manner whatsoever and accordingly ,Dr.Reddys does not recommend , endorse or make any representation about the veracity and appropriateness of the views ,opinions/ information on MedEnrich website. Content on MedEnrich website may discuss uses and dosage for therapeutic product that may not have been approved in by the relevant regulatory agencies in your country. Dr.Reddy’s does not support , endorse or encourage any off-label use. Please refer to approved label before prescribing.

Perks of registering with us
Access to Online/Offline Events
Personalized Content
Access to all Features
Hi, can I help?
Chat SupportX
Support Team
Hello, how can I help you today?
Please select one of the below options.

Find Information

Unable to Login or Register

Want to share feedback